TABLE 1.
Assessment of transmission of Babesia caballi via direct blood transfer and tick feeding following antimicrobial treatment
Donor horse | Recipient horse | Transmission model | Result of indicated test for recipient horse
|
|||
---|---|---|---|---|---|---|
Pretransmission
|
Posttransmission (no. of days)
|
|||||
Nested PCR | C-ELISA | Nested PCR | C-ELISA | |||
Ho-133a | Ho-121 | Intravenous | − | − | + (8) | + (8) |
Ho-146a | Ho-122 | Intravenous | − | − | + (8) | + (8) |
Ho-145b | Ho-126 | Intravenous | − | − | − (>100) | − (>100) |
Ho-147b | Ho-127 | Intravenous | − | − | − (>100) | − (>100) |
Ho-133a | Ho-150 | Tick borne | − | − | + (12) | + (12) |
Ho-146a | Ho-155 | Tick borne | − | − | + (12) | + (12) |
Ho-145b | Ho-154 | Tick borne | − | − | − (>100) | − (>100) |
Ho-147b | Ho-153 | Tick borne | − | − | − (>100) | − (>100) |
Ho-105c | Ho-137 | Tick borne | − | − | − (>100) | − (>100 days) |
Untreated horse.
Horse treated with imidocarb dipropionate.
Uninfected (negative control) horse.